This is a very exciting time in the field of ophthalmology research! New advancements in the treatment of eye disease like age-related macular degeneration (AMD) are becoming more and more available and accessible to patients.
A top priority of our SupportSightSM Program is to provide the latest and most credible information to help you learn more about viable advancements and connect you directly to specific opportunities that may be right for you.
Today, there’s a lot of buzz about a treatment program which attempts to restore central vision using a tiny telescope implant for eligible people who have lost their sight as a result of AMD. The potential overall benefit of the implant is improved vision, helping you perform everyday tasks such as pouring a cup of coffee, reading large print or writing your shopping list – ultimately living a more independent life.
Recent changes in eligibility have allowed this treatment to become more available to a wider range of patients. Potential candidates (you or a loved one) need to consider the following:
- Are you 65 years of age or older?
- Do you have AMD in both eyes?
- Does it affect your ability to read or recognize facial expressions?
Please call Lynn Rinaldi,
SupportSightSM program manager,
at 1-866-462-2852 or email lynn@mvrf.org.
Click here to view the
CentraSight Treatment Program Fact Sheet
